News: May 2013

MAY 2013

Dialog reaches valuation milestone and seeks trade sale

Dialog Devices Ltd has successfully developed and CE Marked Padd® in Europe where it is approved ‘as an aid in the diagnosis of PAD’ and has a 510k application ready to file in the USA. The next exciting steps for Padd® are European launch, regulatory clearance and launch in the USA and major markets globally, and development and launch of further products exploiting the Padd® technology. 

The Board of Dialog, following discussions with its shareholders and advisors, is now seeking a sale of the business to maximise the commercial return for Padd®. Dialog offers an acquirer an excellent opportunity to purchase an innovative technology company including Padd®, its IPR portfolio, patents, trademarks and know-how.

Contact Alan Edwards, Chairman for further information:

alan.edwards@dialogdevices.co.uk

Download more information

Dialog reaches valuation milestone and seeks trade sale